- SENSEXNIFTY 50
Gujarat-based Supreme Industries has received the drug regulator's go-ahead to conduct phase-one human trials for its inhalation therapy to treat COVID-19.
The therapy, called LifeViroTreat, has been developed in collaboration with Hyderabad-based Lifeactivers. Timsy Jaipuria reports that this is a 3-day inhalation therapy and the company claims that it can completely kill the COVID-19 virus from the respiratory tract.
The company had submitted animal trial data to the subject expert committee (SEC) and had said that this is a chlorine gas product administered in 1mg doses and involves two dose nebulisation or inhalation for three days.
Watch video for more.
